COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,511,201 | +662.9% | 1,473,583 | +771.0% | 0.00% | – |
Q2 2023 | $722,377 | -81.4% | 169,175 | -70.2% | 0.00% | – |
Q1 2023 | $3,880,839 | +28.1% | 567,374 | +48.4% | 0.00% | – |
Q4 2022 | $3,029,004 | +16.3% | 382,450 | +41.1% | 0.00% | – |
Q3 2022 | $2,605,000 | +35.0% | 271,080 | +1.7% | 0.00% | – |
Q2 2022 | $1,929,000 | -39.4% | 266,638 | +8.1% | 0.00% | – |
Q1 2022 | $3,183,000 | -3.3% | 246,593 | +19.6% | 0.00% | – |
Q4 2021 | $3,291,000 | -22.1% | 206,213 | -21.5% | 0.00% | – |
Q3 2021 | $4,222,000 | +21.1% | 262,747 | +4.3% | 0.00% | – |
Q2 2021 | $3,485,000 | +61.8% | 251,987 | +70.8% | 0.00% | – |
Q1 2021 | $2,154,000 | -32.9% | 147,524 | -20.1% | 0.00% | – |
Q4 2020 | $3,211,000 | +131.2% | 184,743 | +144.0% | 0.00% | – |
Q3 2020 | $1,389,000 | -5.7% | 75,713 | -8.2% | 0.00% | – |
Q2 2020 | $1,473,000 | +0.9% | 82,460 | -8.4% | 0.00% | – |
Q1 2020 | $1,460,000 | +91.6% | 89,992 | +112.7% | 0.00% | – |
Q4 2019 | $762,000 | -37.0% | 42,313 | -29.1% | 0.00% | – |
Q3 2019 | $1,210,000 | -47.4% | 59,705 | -42.6% | 0.00% | – |
Q2 2019 | $2,301,000 | -21.6% | 104,097 | -51.6% | 0.00% | – |
Q1 2019 | $2,935,000 | +156.8% | 215,149 | +70.3% | 0.00% | – |
Q4 2018 | $1,143,000 | +37.4% | 126,325 | +150.7% | 0.00% | – |
Q3 2018 | $832,000 | -5.7% | 50,397 | -19.9% | 0.00% | – |
Q2 2018 | $882,000 | +17.0% | 62,940 | -7.7% | 0.00% | – |
Q1 2018 | $754,000 | +242.7% | 68,184 | +172.4% | 0.00% | – |
Q4 2017 | $220,000 | -61.1% | 25,029 | -40.9% | 0.00% | – |
Q3 2017 | $566,000 | -71.2% | 42,326 | -69.1% | 0.00% | – |
Q2 2017 | $1,966,000 | +408.0% | 136,980 | +648.2% | 0.00% | – |
Q1 2017 | $387,000 | +103.7% | 18,308 | +171.0% | 0.00% | – |
Q4 2016 | $190,000 | -82.0% | 6,755 | -82.9% | 0.00% | – |
Q3 2016 | $1,058,000 | +1174.7% | 39,509 | +706.8% | 0.00% | – |
Q2 2016 | $83,000 | +151.5% | 4,897 | +218.0% | 0.00% | – |
Q1 2016 | $33,000 | -81.6% | 1,540 | -80.3% | 0.00% | – |
Q4 2015 | $179,000 | +678.3% | 7,814 | +595.2% | 0.00% | – |
Q3 2015 | $23,000 | -53.1% | 1,124 | -33.9% | 0.00% | – |
Q2 2015 | $49,000 | +4800.0% | 1,701 | +9350.0% | 0.00% | – |
Q1 2015 | $1,000 | – | 18 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |